⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 15, 2024Open Access

Supplementary Figure 3 from Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling

Zhuo-Ying Tao Leilei Wang Wang‐Yong Zhu Gao Zhang Yu‐Xiong Su

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 3. Galunisertib reserves the tumor cell aggressiveness and downregulates TGFbeta signaling and PD-L1 expression of tumor cells in the neuron-tumor coculture system.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tao et al. (2024) studied this question.

synapsesocial.com/papers/68e7917cb6db643587702a63 https://doi.org/10.1158/2767-9764.25225880

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 3 from Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling2024
2FIGURE 4 from Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling2024
3Supplementary Figure 1 from Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling2024
4Supplementary Figure 1 from Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling2024
5Supplementary Figure 2 from Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling2024